Cargando…
Idiopathic pulmonary fibrosis and lung cancer: future directions and challenges
Idiopathic pulmonary fibrosis (IPF) is a progressive disease of pulmonary scarring. New treatments slow disease progression and allow pulmonary fibrosis patients to live longer. Persistent pulmonary fibrosis increases a patient's risk of developing lung cancer. Lung cancer in patients with IPF...
Autores principales: | Abu Qubo, Ahmad, Numan, Jamil, Snijder, Juan, Padilla, Maria, Austin, John H.M., Capaccione, Kathleen M., Pernia, Monica, Bustamante, Jean, O'Connor, Timothy, Salvatore, Mary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973524/ https://www.ncbi.nlm.nih.gov/pubmed/36865932 http://dx.doi.org/10.1183/20734735.0147-2022 |
Ejemplares similares
-
The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
por: Abu Qubo, Ahmad, et al.
Publicado: (2022) -
Fibrosis
por: Pernia Marin, Monica, et al.
Publicado: (2023) -
Analogies between the periphery of cancer and the leading edge of pulmonary fibrosis
por: Pernia Marin, Monica, et al.
Publicado: (2023) -
Pulmonary embolism rate in patients infected with SARS-CoV-2
por: Capaccione, Kathleen M., et al.
Publicado: (2020) -
COVID-19 on Chest CT: Translating Known Microscopic Findings to Imaging Observations
por: Dsouza, Belinda, et al.
Publicado: (2022)